Innovation
DPC is working to ensure that there are appropriate incentives in the Medicare ESRD program to encourage innovation in the field. We are also partnering with members of the kidney and greater medical community to provide the patient voice in new research projects. All those affected by kidney disease know how vital access to high quality care is to living a full and meaningful life. DPC is committed to working with the kidney community to ensure that all care provided in this country meets the highest quality and patient safety standards so all of our members can live life to the fullest.
Related Information
DPC Asks Medicare Officials to Reverse Pruritis Drug Fiasco
In a letter to the Center for Medicare and Medicaid Services (CMS), Dialysis Patient Citizens (DPC) asked for a “do-over” in the rollout of Korsuva, a drug that treats ESRD-related pruritis. Medicare makes an add-on [...]
DPC’s Letter to Hon. Jonathan Blum, Principal Deputy Administrator for CMS, on New Drugs in the ESRD PPS
June 11, 2024 The Honorable Jonathan Blum Principal Deputy Administrator Centers for Medicare & Medicaid Services 200 Independence Avenue, SW Washington, DC 20515 Re: New drugs in the ESRD PPS Dear Principal Deputy Administrator [...]
DPC Seeks Information on Patients’ Experience With Itching
A couple of years ago, a new drug was approved to treat ESRD-related pruritis. Medicare approved an additional payment for the drug Korsuva for a period of 2 years. But, because of the short expiration [...]
The Trouble With Bundles
This op-ed was written by Jackson Williams, DPC Vice President of Public Policy, and originally published on AMJC's website: www.ajmc.com/view/contributor-the-trouble-with-bundles. Payment bundling is a technique aimed at increasing efficiency and reducing low-value care during a [...]
DPC Expresses Outrage at CMS Indifference to Dialysis Patient Suffering
On October 27, 2023, the Centers for Medicare & Medicaid Services (CMS) issued its final rule updating payment rates and policies under the end-stage renal disease (ESRD) prospective payment system. This rule fails to [...]
Dialysis Patient Citizens Responds to Disappointing Final CMS Rule That Will Harm Patient Healthcare
WASHINGTON, D.C. (October 30, 2023) - Dialysis Patient Citizens (DPC), the nation’s largest patient-led, non-profit advocacy group for dialysis patients, released the following statement in response to the final rule issued by the Centers [...]
